APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAPI for Tumor Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FAPI for Tumor Treatment Industry Growth and Trends Forecast to 2032

28 December 202571 pages

Choose your research edition.

Industry ResearchFAPI for Tumor Treatment Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal FAPI for Tumor Treatment Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal FAPI for Tumor Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAPI for Tumor Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal FAPI for Tumor Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global FAPI for Tumor Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FAPI for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FAPI for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FAPI for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FAPI for Tumor Treatment include Clovis Oncology, Bayer and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FAPI for Tumor Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FAPI for Tumor Treatment market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FAPI for Tumor Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FAPI for Tumor Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global FAPI for Tumor Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FAPI for Tumor Treatment Market by Company

Clovis Oncology

Bayer

Novartis AG

FAPI for Tumor Treatment Segment by Type

Beta-emitter

Alpha-emitter

FAPI for Tumor Treatment Segment by Application

NSCLC

Pancreatic Cancer

Breast Cancer

Others

FAPI for Tumor Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAPI for Tumor Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAPI for Tumor Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAPI for Tumor Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FAPI for Tumor Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of FAPI for Tumor Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Beta-emitter Table 2. Major Company of Alpha-emitter Table 3. Global FAPI for Tumor Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 5. Global FAPI for Tumor Treatment Sales Market Share in Volume by Type (2021-2026) Table 6. Global FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 7. Global FAPI for Tumor Treatment Sales Market Share in Value by Type (2021-2026) Table 8. Global FAPI for Tumor Treatment Price by Type (2021-2026) & (US$/Unit) Table 9. Global FAPI for Tumor Treatment Sales by Type (2027-2032) & (K Units) Table 10. Global FAPI for Tumor Treatment Sales Market Share in Volume by Type (2027-2032) Table 11. Global FAPI for Tumor Treatment Sales by Type (2027-2032) & (US$ Million) Table 12. Global FAPI for Tumor Treatment Sales Market Share in Value by Type (2027-2032) Table 13. Global FAPI for Tumor Treatment Price by Type (2027-2032) & (US$/Unit) Table 14. North America FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 15. North America FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 16. Europe FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 17. Europe FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 21. Latin America FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa FAPI for Tumor Treatment Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa FAPI for Tumor Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. FAPI for Tumor Treatment Industry Trends Table 25. FAPI for Tumor Treatment Industry Drivers Table 26. FAPI for Tumor Treatment Industry Opportunities and Challenges Table 27. FAPI for Tumor Treatment Industry Restraints Table 28. Global FAPI for Tumor Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global FAPI for Tumor Treatment Revenue Market Share by Company (2021-2026) Table 30. Global FAPI for Tumor Treatment Sales by Company (2021-2026) & (K Units) Table 31. Global FAPI for Tumor Treatment Sales Share by Company (2021-2026) Table 32. Global FAPI for Tumor Treatment Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global FAPI for Tumor Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global FAPI for Tumor Treatment Major Company Production Sites and Headquarters Table 35. Global FAPI for Tumor Treatment Company, Product Type & Application Table 36. Global FAPI for Tumor Treatment Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global FAPI for Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global FAPI for Tumor Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global FAPI for Tumor Treatment Sales by Region (2021-2026) & (K Units) Table 41. Global FAPI for Tumor Treatment Sales Market Share in Volume by Region (2021-2026) Table 42. Global FAPI for Tumor Treatment Sales by Region (2021-2026) & (US$ Million) Table 43. Global FAPI for Tumor Treatment Sales Market Share in Value by Region (2021-2026) Table 44. Global FAPI for Tumor Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global FAPI for Tumor Treatment Sales by Region (2027-2032) & (K Units) Table 46. Global FAPI for Tumor Treatment Sales Market Share in Volume by Region (2027-2032) Table 47. Global FAPI for Tumor Treatment Sales by Region (2027-2032) & (US$ Million) Table 48. Global FAPI for Tumor Treatment Sales Market Share in Value by Region (2027-2032) Table 49. Global FAPI for Tumor Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global FAPI for Tumor Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 52. Global FAPI for Tumor Treatment Sales Market Share in Volume by Application (2021-2026) Table 53. Global FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 54. Global FAPI for Tumor Treatment Sales Market Share in Value by Application (2021-2026) Table 55. Global FAPI for Tumor Treatment Price by Application (2021-2026) & (US$/Unit) Table 56. Global FAPI for Tumor Treatment Sales by Application (2027-2032) & (K Units) Table 57. Global FAPI for Tumor Treatment Sales Market Share in Volume by Application (2027-2032) Table 58. Global FAPI for Tumor Treatment Sales by Application (2027-2032) & (US$ Million) Table 59. Global FAPI for Tumor Treatment Sales Market Share in Value by Application (2027-2032) Table 60. Global FAPI for Tumor Treatment Price by Application (2027-2032) & (US$/Unit) Table 61. North America FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 62. North America FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 63. Europe FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 64. Europe FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 68. Latin America FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa FAPI for Tumor Treatment Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa FAPI for Tumor Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Clovis Oncology Company Information Table 72. Clovis Oncology Business Overview Table 73. Clovis Oncology FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Clovis Oncology FAPI for Tumor Treatment Product Portfolio Table 75. Clovis Oncology Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer FAPI for Tumor Treatment Product Portfolio Table 80. Bayer Recent Development Table 81. Novartis AG Company Information Table 82. Novartis AG Business Overview Table 83. Novartis AG FAPI for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis AG FAPI for Tumor Treatment Product Portfolio Table 85. Novartis AG Recent Development Table 86. North America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 88. North America FAPI for Tumor Treatment Sales Market Share by Country (2021-2026) Table 89. North America FAPI for Tumor Treatment Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America FAPI for Tumor Treatment Sales Market Share Forecast by Country (2027-2032) Table 91. North America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America FAPI for Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 93. North America FAPI for Tumor Treatment Market Share by Country (2021-2026) Table 94. North America FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America FAPI for Tumor Treatment Market Share Forecast by Country (2027-2032) Table 96. Europe FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 98. Europe FAPI for Tumor Treatment Sales Market Share by Country (2021-2026) Table 99. Europe FAPI for Tumor Treatment Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe FAPI for Tumor Treatment Sales Market Share Forecast by Country (2027-2032) Table 101. Europe FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe FAPI for Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe FAPI for Tumor Treatment Market Share by Country (2021-2026) Table 104. Europe FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe FAPI for Tumor Treatment Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific FAPI for Tumor Treatment Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific FAPI for Tumor Treatment Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific FAPI for Tumor Treatment Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific FAPI for Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific FAPI for Tumor Treatment Market Share by Country (2021-2026) Table 114. Asia-Pacific FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific FAPI for Tumor Treatment Market Share Forecast by Country (2027-2032) Table 116. Latin America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 118. Latin America FAPI for Tumor Treatment Sales Market Share by Country (2021-2026) Table 119. Latin America FAPI for Tumor Treatment Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America FAPI for Tumor Treatment Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America FAPI for Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America FAPI for Tumor Treatment Market Share by Country (2021-2026) Table 124. Latin America FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America FAPI for Tumor Treatment Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa FAPI for Tumor Treatment Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa FAPI for Tumor Treatment Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa FAPI for Tumor Treatment Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa FAPI for Tumor Treatment Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa FAPI for Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa FAPI for Tumor Treatment Market Share by Country (2021-2026) Table 134. Middle East and Africa FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa FAPI for Tumor Treatment Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. FAPI for Tumor Treatment Distributors List Table 139. FAPI for Tumor Treatment Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. FAPI for Tumor Treatment Image Figure 2. Global FAPI for Tumor Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAPI for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global FAPI for Tumor Treatment Sales (2021-2032) & (K Units) Figure 5. Beta-emitter Image Figure 6. Global Beta-emitter Sales YoY Growth (2021-2032) & (K Units) Figure 7. Alpha-emitter Image Figure 8. Global Alpha-emitter Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global FAPI for Tumor Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global FAPI for Tumor Treatment Market Share by Type 2025 VS 2032 Figure 11. North America FAPI for Tumor Treatment Sales Market Share in Volume by Type in 2025 Figure 12. North America FAPI for Tumor Treatment Sales Market Share in Value by Type in 2025 Figure 13. Europe FAPI for Tumor Treatment Sales Market Share in Volume by Type in 2025 Figure 14. Europe FAPI for Tumor Treatment Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific FAPI for Tumor Treatment Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific FAPI for Tumor Treatment Sales Market Share in Value by Type in 2025 Figure 17. Latin America FAPI for Tumor Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Latin America FAPI for Tumor Treatment Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa FAPI for Tumor Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa FAPI for Tumor Treatment Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 FAPI for Tumor Treatment Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. NSCLC Image Figure 24. Global NSCLC Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pancreatic Cancer Image Figure 26. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global FAPI for Tumor Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global FAPI for Tumor Treatment Market Share by Application 2025 VS 2032 Figure 33. North America FAPI for Tumor Treatment Sales Market Share in Volume by Application in 2025 Figure 34. North America FAPI for Tumor Treatment Sales Market Share in Value by Application in 2025 Figure 35. Europe FAPI for Tumor Treatment Sales Market Share in Volume by Application in 2025 Figure 36. Europe FAPI for Tumor Treatment Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific FAPI for Tumor Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific FAPI for Tumor Treatment Sales Market Share in Value by Application in 2025 Figure 39. Latin America FAPI for Tumor Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Latin America FAPI for Tumor Treatment Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa FAPI for Tumor Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa FAPI for Tumor Treatment Sales Market Share in Value by Application in 2025 Figure 43. North America FAPI for Tumor Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America FAPI for Tumor Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America FAPI for Tumor Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America FAPI for Tumor Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe FAPI for Tumor Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe FAPI for Tumor Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe FAPI for Tumor Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe FAPI for Tumor Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific FAPI for Tumor Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific FAPI for Tumor Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific FAPI for Tumor Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific FAPI for Tumor Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America FAPI for Tumor Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America FAPI for Tumor Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America FAPI for Tumor Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America FAPI for Tumor Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa FAPI for Tumor Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa FAPI for Tumor Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa FAPI for Tumor Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa FAPI for Tumor Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. FAPI for Tumor Treatment Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. FAPI for Tumor Treatment Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Beta-emitter
  • Alpha-emitter
Applications
  • NSCLC
  • Pancreatic Cancer
  • Breast Cancer
  • Others
Companies covered
  • Clovis Oncology
  • Bayer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global FAPI for Tumor Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global FAPI for Tumor Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 FAPI for Tumor Treatment Market by Type
  6. 1.3.1 Beta-emitter
  7. 1.3.2 Alpha-emitter
  8. 1.4 Global FAPI for Tumor Treatment Market Size by Type
  9. 1.4.1 Global FAPI for Tumor Treatment Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global FAPI for Tumor Treatment Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global FAPI for Tumor Treatment Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America FAPI for Tumor Treatment Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe FAPI for Tumor Treatment Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific FAPI for Tumor Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America FAPI for Tumor Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa FAPI for Tumor Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 FAPI for Tumor Treatment Industry Trends
  2. 2.2 FAPI for Tumor Treatment Industry Drivers
  3. 2.3 FAPI for Tumor Treatment Industry Opportunities and Challenges
  4. 2.4 FAPI for Tumor Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by FAPI for Tumor Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by FAPI for Tumor Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by FAPI for Tumor Treatment Price (2021-2026)
  4. 3.4 Global FAPI for Tumor Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FAPI for Tumor Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global FAPI for Tumor Treatment Company, Product Type & Application
  7. 3.7 Global FAPI for Tumor Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FAPI for Tumor Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FAPI for Tumor Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FAPI for Tumor Treatment Tier 1, Tier 2, and Tier 3
4 FAPI for Tumor Treatment Regional Status and Outlook
  1. 4.1 Global FAPI for Tumor Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global FAPI for Tumor Treatment Historic Market Size by Region
  3. 4.2.1 Global FAPI for Tumor Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global FAPI for Tumor Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global FAPI for Tumor Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global FAPI for Tumor Treatment Forecasted Market Size by Region
  7. 4.3.1 Global FAPI for Tumor Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global FAPI for Tumor Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global FAPI for Tumor Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 FAPI for Tumor Treatment by Application
  1. 5.1 FAPI for Tumor Treatment Market by Application
  2. 5.1.1 NSCLC
  3. 5.1.2 Pancreatic Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global FAPI for Tumor Treatment Market Size by Application
  7. 5.2.1 Global FAPI for Tumor Treatment Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global FAPI for Tumor Treatment Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global FAPI for Tumor Treatment Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America FAPI for Tumor Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe FAPI for Tumor Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific FAPI for Tumor Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America FAPI for Tumor Treatment Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa FAPI for Tumor Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Clovis Oncology
  2. 6.1.1 Clovis Oncology Company Information
  3. 6.1.2 Clovis Oncology Business Overview
  4. 6.1.3 Clovis Oncology FAPI for Tumor Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Clovis Oncology FAPI for Tumor Treatment Product Portfolio
  6. 6.1.5 Clovis Oncology Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer FAPI for Tumor Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer FAPI for Tumor Treatment Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Novartis AG
  14. 6.3.1 Novartis AG Company Information
  15. 6.3.2 Novartis AG Business Overview
  16. 6.3.3 Novartis AG FAPI for Tumor Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis AG FAPI for Tumor Treatment Product Portfolio
  18. 6.3.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America FAPI for Tumor Treatment Sales by Country
  2. 7.1.1 North America FAPI for Tumor Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America FAPI for Tumor Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America FAPI for Tumor Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America FAPI for Tumor Treatment Market Size by Country
  6. 7.2.1 North America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America FAPI for Tumor Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe FAPI for Tumor Treatment Sales by Country
  2. 8.1.1 Europe FAPI for Tumor Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe FAPI for Tumor Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe FAPI for Tumor Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe FAPI for Tumor Treatment Market Size by Country
  6. 8.2.1 Europe FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe FAPI for Tumor Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific FAPI for Tumor Treatment Sales by Country
  2. 9.1.1 Asia-Pacific FAPI for Tumor Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific FAPI for Tumor Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific FAPI for Tumor Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific FAPI for Tumor Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific FAPI for Tumor Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America FAPI for Tumor Treatment Sales by Country
  2. 10.1.1 South America FAPI for Tumor Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America FAPI for Tumor Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America FAPI for Tumor Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America FAPI for Tumor Treatment Market Size by Country
  6. 10.2.1 South America FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America FAPI for Tumor Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa FAPI for Tumor Treatment Sales by Country
  2. 11.1.1 Middle East and Africa FAPI for Tumor Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa FAPI for Tumor Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa FAPI for Tumor Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa FAPI for Tumor Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa FAPI for Tumor Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa FAPI for Tumor Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa FAPI for Tumor Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 FAPI for Tumor Treatment Value Chain Analysis
  2. 12.1.1 FAPI for Tumor Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 FAPI for Tumor Treatment Production Mode & Process
  7. 12.2 FAPI for Tumor Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 FAPI for Tumor Treatment Distributors
  10. 12.2.3 FAPI for Tumor Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst